Invasive breast cancer is a malignant tumor that originates from the ductal epithelium or lobules of the breast. After aggressive and standardized treatment, the 5-year survival rate of patients with invasive breast cancer is about 95% according to the stage of the tumor: 1) Stage I; 2) Stage IIA; 5) Stage IIB; 5) Stage IIB; 5) Stage IIIA; 5) Stage IIIB; 5) Stage IIIA; 5) Stage IIIB; 5) Stage IV; 5) Stage IV; 5) Stage IV; 5) Stage IV; 5) The 5-year survival rate for stage IV is about 18%. The treatment of invasive breast cancer is mainly surgical, but generally, according to the pathological results of the tumor and the patient’s physical condition, multiple treatments are combined, including radiotherapy, chemotherapy, endocrine therapy and targeted therapy. After standardized treatment, patients should pay attention to regular review and timely detection of recurrence.